☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Almirall Exercises its Option to License Dermira's Lebrikizumab for Atopic Dermatitis in Europe
June 26, 2019
Tilt Biotherapeutics Signs an Agreement with Merck KGaA and Pfizer to Investigate the Dual Combination for Solid Tumors
June 26, 2019
Eisai Reports Results of Fycompa (perampanel) in P-III FREEDOM Study for Patients with Newly Diagnosed or Untreated Partial Onset...
June 26, 2019
Lilly Reports Results of Trulicity (dulaglutide) in P-III AWARD-11 Study for Type 2 Diabetes
June 26, 2019
Boehringer Ingelheim and Eli Lilly's Empagliflozin Receive FDA's Fast Track Designation for Chronic Heart Failure
June 26, 2019
Daiichi Sankyo to Return Exclusive Development and Commercialization Rights for Four Diagnostic Imaging Agents to GE Healthcare in...
June 26, 2019
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions